Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Ordi-Ros

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Medicina Clinica|July 9, 2013
[Current therapeutic indications of thalidomide and lenalidomide]Josep Ordi-Ros, Francisco Javier Cosiglio
Annals of the New York Academy of Sciences|September 26, 2007
DNA methylation and systemic lupus erythematosusEva Balada, Josep Ordi-Ros, Miquel Vilardell-Tarrés
International Reviews of Immunology|July 20, 2010
Implication of human endogenous retroviruses in the development of autoimmune diseasesEva Balada, Miquel Vilardell-Tarrés, Josep Ordi-Ros
Reviews in Medical Virology|August 29, 2009
Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunityEva Balada, Josep Ordi-Ros, Miquel Vilardell-Tarrés
Autoimmunity Reviews|May 20, 2008
The complex immunogenetic basis of systemic lupus erythematosusJesús Castro, Eva Balada, Josep Ordi-Ros, et al.
British Journal of Haematology|August 8, 2009
Genetic risk factors of thrombosis in the antiphospholipid syndromeJesús Castro-Marrero, Eva Balada, Miquel Vilardell-Tarrés, et al.
Autoimmunity Reviews|May 20, 2008
DNase 1 and systemic lupus erythematosusFernando Martínez Valle, Eva Balada, Josep Ordi-Ros, et al.
Arthritis Research & Therapy|December 11, 2012
Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosusJosefina Cortés-Hernández, Gabriela Ávila, Miquel Vilardell-Tarrés, et al.
Seminars in Arthritis and Rheumatism|February 26, 2015
Etanercept in refractory lupus arthritis: An observational studyJosefina Cortés-Hernández, Natalia Egri, Miquel Vilardell-Tarrés, et al.
Cells|July 28, 2019
An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus NephritisCristina Solé, Teresa Moliné, Marta Vidal, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Medicina Clinica|July 9, 2013
[Current therapeutic indications of thalidomide and lenalidomide]Josep Ordi-Ros, Francisco Javier Cosiglio
Annals of the New York Academy of Sciences|September 26, 2007
DNA methylation and systemic lupus erythematosusEva Balada, Josep Ordi-Ros, Miquel Vilardell-Tarrés
International Reviews of Immunology|July 20, 2010
Implication of human endogenous retroviruses in the development of autoimmune diseasesEva Balada, Miquel Vilardell-Tarrés, Josep Ordi-Ros
Reviews in Medical Virology|August 29, 2009
Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunityEva Balada, Josep Ordi-Ros, Miquel Vilardell-Tarrés
Autoimmunity Reviews|May 20, 2008
The complex immunogenetic basis of systemic lupus erythematosusJesús Castro, Eva Balada, Josep Ordi-Ros, et al.
British Journal of Haematology|August 8, 2009
Genetic risk factors of thrombosis in the antiphospholipid syndromeJesús Castro-Marrero, Eva Balada, Miquel Vilardell-Tarrés, et al.
Autoimmunity Reviews|May 20, 2008
DNase 1 and systemic lupus erythematosusFernando Martínez Valle, Eva Balada, Josep Ordi-Ros, et al.
Arthritis Research & Therapy|December 11, 2012
Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosusJosefina Cortés-Hernández, Gabriela Ávila, Miquel Vilardell-Tarrés, et al.
Seminars in Arthritis and Rheumatism|February 26, 2015
Etanercept in refractory lupus arthritis: An observational studyJosefina Cortés-Hernández, Natalia Egri, Miquel Vilardell-Tarrés, et al.
Cells|July 28, 2019
An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus NephritisCristina Solé, Teresa Moliné, Marta Vidal, et al.
Pageof 4